全文获取类型
收费全文 | 1606篇 |
免费 | 113篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 91篇 |
妇产科学 | 14篇 |
基础医学 | 183篇 |
口腔科学 | 45篇 |
临床医学 | 194篇 |
内科学 | 255篇 |
皮肤病学 | 32篇 |
神经病学 | 157篇 |
特种医学 | 373篇 |
外科学 | 92篇 |
综合类 | 24篇 |
一般理论 | 1篇 |
预防医学 | 60篇 |
眼科学 | 6篇 |
药学 | 130篇 |
肿瘤学 | 70篇 |
出版年
2021年 | 21篇 |
2020年 | 7篇 |
2019年 | 18篇 |
2018年 | 40篇 |
2017年 | 14篇 |
2016年 | 11篇 |
2015年 | 24篇 |
2014年 | 24篇 |
2013年 | 44篇 |
2012年 | 38篇 |
2011年 | 31篇 |
2010年 | 44篇 |
2009年 | 39篇 |
2008年 | 35篇 |
2007年 | 64篇 |
2006年 | 42篇 |
2005年 | 41篇 |
2004年 | 56篇 |
2003年 | 42篇 |
2002年 | 29篇 |
2001年 | 24篇 |
2000年 | 27篇 |
1999年 | 34篇 |
1998年 | 103篇 |
1997年 | 71篇 |
1996年 | 84篇 |
1995年 | 57篇 |
1994年 | 57篇 |
1993年 | 64篇 |
1992年 | 20篇 |
1991年 | 23篇 |
1990年 | 21篇 |
1989年 | 49篇 |
1988年 | 37篇 |
1987年 | 51篇 |
1986年 | 31篇 |
1985年 | 33篇 |
1984年 | 31篇 |
1983年 | 17篇 |
1982年 | 23篇 |
1981年 | 25篇 |
1980年 | 33篇 |
1979年 | 19篇 |
1978年 | 21篇 |
1977年 | 25篇 |
1976年 | 21篇 |
1975年 | 14篇 |
1973年 | 13篇 |
1968年 | 5篇 |
1967年 | 5篇 |
排序方式: 共有1730条查询结果,搜索用时 31 毫秒
1.
Needle-localized breast biopsy: why do we fail? 总被引:10,自引:0,他引:10
2.
Ketai LH; Williamson MR; Telepak RJ; Levy H; Koster FT; Nolte KB; Allen SE 《Radiology》1994,191(3):665
3.
C. J. Waddington K. A. Enyimayew 《The International journal of health planning and management》1989,4(1):17-47
In present constrained economic circumstances, many governments have introduced or increased user charges for health services. This has been advocated by the World Bank, justified by reference to the raising of revenue, efficiency and, controversially, even the promotion of equity. This paper examines the impact of user charges on utilisation in the Ashanti-Akim district of Ghana since the introduction of charges in 1985. In many ways, user charges have been a success: in recovering fees and maintaining urban utilisation. However some advantages have not materialised because the health infrastructure has not changed adequately. More importantly, equity and affordability have been problematical. For some of the population, services are no longer affordable. 相似文献
4.
5.
荧光原位杂交技术分析人结肠菌群方法研究 总被引:2,自引:0,他引:2
建立荧光原位杂交技术分析人体内结肠菌群的方法。取受试者新鲜粪便 ,选用 5种特异性的 16SrRNA寡核苷酸探针 ,检测粪便样本收集后的保存时间、温度 ,离心条件及样本固定液存放时间对杂交计数结果的影响。结果建立最佳实验条件为 :粪便样本收集后应尽快在 4℃下保存 ,放置时间不要超过 12小时即作处理 ;样本的适宜离心条件为 70 0g 2分钟 ;样本用多聚甲醛固定后在 - 80℃下存放时间不要超过 5个月。该方法具有较好的稳定性 ,可以有效地检出个体之间结肠菌群的差异。 相似文献
6.
Geraldo F. Busatto Lyn S. Pilowsky Durval C. Costa John Mertehs Dirk Terriere Peter J. Ell Rachel Mulligan Michael J. Travis Josée E. Leysen Dominic Lui Sveto Gacinovic Wendy Waddington Anne Lingford-Hughes Robert W. Kerwin 《European journal of nuclear medicine and molecular imaging》1997,24(2):119-124
The mapping of 5-HT2 receptors in the brain using functional imaging techniques has been limited by a relative lack of selective radioligands.
Iodine-123 labelled 4-amino-N-[1-[3-(4-fluorophenoxy)propyl]-4-methyl-4-piperidinyl]-5-iodo-2-methoxybenzamide (123I-5-I-R91150 or123I-R93274) is a new ligand for single-photon emission tomography (SPET), with high affinity and selectivity for 5-HT2A receptors. This study reports on preliminary123I-5-I-R91150 SPET, wholebody and blood distribution findings in five healthy human volunteers. Maximal brain uptake was approximately
2% of total body counts at 180 min post injection (p.i.). Dynamic SPET sequences were acquired with the brain-dedicated, single-slice
multi-detector system SEM-810 over 200 min p.i. Early peak uptake (at 5 min p.i.) was seen in the cerebellum, a region free
from 5HT2A receptors. In contrast, radioligand binding in the frontal cortex increased steadily over time, up to a peak at approximately
100–120 min p.i. Frontal cortex-cerebellum activity ratios reached values of 1.4, and remained stable from approximately 100
min p.i. onwards. Multi-slice SPET sequences showed a pattern of regional variation of binding compatible with the autoradiographic
data on the distribution of 5-HT2A receptors in (cerebral cortex>striatum>cerebellum). These findings suggest that123I-5-I-R91150 may be used for the imaging of 5-HT2A receptors in the living human brain with SPET. 相似文献
7.
8.
The effects of agonist and antagonist compounds on the equilibrium binding of the D1 antagonist ligand [3H]SCH 23390 were examined in membranes from the striatum of the rat. The antagonist SK&F 83566 interacted with D1 receptors in the manner of a competitive antagonist, causing a decrease in the affinity of the binding of [3H]SCH 23390, without altering the maximum number of binding sites (Bmax). The interaction of agonist compounds with the D1 receptor appeared to be more complex. The drug SK&F 75670, a weak partial agonist, also acted competitively at D1 sites. However, agonists with moderate (SK&F 38393, CY 208-243) or full (dopamine) intrinsic activity to stimulate adenylate cyclase, interacted with D1 binding sites in a mixed competitive/non-competitive manner, causing both a decrease in ligand affinity and a decrease in Bmax. The benzazepine analogue, which also has full agonist activity, SK&F 82958, only caused a reduction in Bmax. Furthermore, there was a positive relationship between the intrinsic activity of agonists and the magnitude of the reductions in Bmax which they induced. In the presence of the GTP analogue, Gpp(NH)p, CY 208-243 no longer caused an apparent reduction in the number of receptors. These data suggests that the apparent loss of D1 receptors, induced by agonists, may result from an interaction with a guanine-nucleotide sensitive, high affinity agonist binding site and that the degree of interaction with this site depends on the intrinsic D1 activity of the agonist. 相似文献
9.
10.
John L Waddington Aiden P Corvin Gary Donohoe Colm M P O'Tuathaigh Kevin J Mitchell Michael Gill 《The Psychiatric clinics of North America》2007,30(3):365-399
This article summarizes the rationale, methods, and results of gene discovery programs in schizophrenia research and describes functional methods of investigating potential candidate genes. It focuses next on the most prominent current candidate genes and describes (1) evidence for their association with schizophrenia and research into the function of each gene; (2) investigation of the clinical phenotypes and endophenotypes associated with each gene, at the levels of psychopathologic, neurocognitive, electrophysiologic, neuroimaging, and neuropathologic findings; and (3) research into the ethologic, cognitive, social, and psychopharmacologic phenotype of mutants with targeted deletion of each gene. It examines gene-gene and gene-environment interactions. Finally, it looks at future directions for research. 相似文献